Financial Review

…Earnings season heats up. Companies affected by trade war. Farmers get $12 billion bailout. It’s hot outside. Financial Review by Sinclair Noe for 07-24-2018 DOW + 197 = 25,241 SPX + 13 = 2820 NAS – 1 = 7840 RUT – 18 = 1680 10 Y – .02 = 2.95% OIL + .87 = 68.76 GOLD + .10 = 1225.10     The S&P 500 index rose to its highest since early February, and to within 2 percent of its late-January record. The Nasdaq hit a new record high. Alphabet jumped over 3.8% following a very strong earnings report that beat both top and bottom line estimates. After accounting for record EU antitrust fine, Alphabet earnings beat expectations by more than $2 a share. A big beat for Biogen; earnings were up in the second quarter and sales climbed 9%. That’s in part thanks to strong demand for spinal atrophy treatment Spinraza, one of the world’s most expensive drugs. A single dose costs upwards of $125,000. Biogen says 20% more patients in the US are now using the drug. AT&T added a net 46,000 postpaid mobile phone subscribers in th